The increase in EIF4G2-related central memory cells, iTreg cells, and Tr1 cells, with little change in most immune cells, may also account for its lack of significant impact in the pancreatic cancer survival analysis (Figure 5B and Figure 6A). This evidence concerns the gene EIF4G2 and familial pancreatic carcinoma.